Polymorphisms of alpha2a adrenergic receptor gene modulates platelet reactivity in response to epinephrine in stable angina patients despite dual antiplatelet therapy and irrespective of CYP2C19

被引：0
|
作者：
Peace, A. J. [1 ]
Mangiacapra, F. [1 ]
Conte, M. [1 ]
Bailleul, E. [2 ]
Delrue, L. [1 ]
Dierickx, K. [1 ]
Fraeyman, A. [2 ]
Meeus, P. [2 ]
Bartunek, J. [1 ]
Barbato, E. [1 ]
机构：
[1] OLV Hosp Aalst, Cardiovasc Ctr, Aalst, Belgium
[2] Onze Lieve Vrouw Hosp, Hematol Dept, Aalst, Belgium
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：249 / 250
页数：2
相关论文
共 50 条
  • [31] VARIABILITY IN RESPONSE: PATTERNS IN PRESCRIBING ANTIPLATELET THERAPY AFTER CYP2C19 GENOTYPING AMONG PATIENTS WITH ACS AND PCI
    Desai, Nihar
    Canestaro, William
    Chaplin, Donald
    Martell, Lori
    Matlin, Olga S.
    Kyrychenko, Pavlo
    Brennan, Troyen A.
    Choudhry, Niteesh K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 : S237 - S237
  • [32] Impact of point-of-care testing for CYP2C19 on platelet inhibition in patients with acute coronary syndrome and early dual antiplatelet therapy in the emergency setting
    Stimpfle, Fabian
    Karathanos, Athanasios
    Droppa, Michal
    Metzger, Janina
    Rath, Dominik
    Mueller, Karin
    Tavlaki, Elli
    Schaeffeler, Elke
    Winter, Stefan
    Schwab, Matthias
    Gawaz, Meinrad
    Geisler, Tobias
    THROMBOSIS RESEARCH, 2014, 134 (01) : 105 - 110
  • [33] Association of α2A-Adrenergic Receptor Genetic Variants with Platelet Reactivity in Chinese Patients on Dual Antiplatelet Therapy Undergoing Percutaneous Coronary Intervention
    SONG Ying
    TANG Xiao Fang
    YAO Yi
    HE Chen
    XU Jing Jing
    WANG Huan Huan
    GAO Zhan
    WANG Miao
    YUAN Jin Qing
    BiomedicalandEnvironmentalSciences, 2017, 30 (12) : 898 - 906
  • [34] Analysis of the Guiding Role of CYP2C19 Gene Combined With Platelet Function Detection in Antiplatelet Therapy in Patients With Complex Coronary Artery Disease After PCI
    Yu, Jiancai
    Liu, Yongxing
    Peng, Wanzhong
    Liu, Juan
    Li, Ya
    Liu, Junyan
    Jiang, Yang
    Liu, Demin
    Xu, Zesheng
    FRONTIERS IN SURGERY, 2022, 9
  • [35] Association of α2A-Adrenergic Receptor Genetic Variants with Platelet Reactivity in Chinese Patients on Dual Antiplatelet Therapy Undergoing Percutaneous Coronary Intervention
    Song, Ying
    Tang, Xiao Fang
    Yao, Yi
    He, Chen
    Xu, Jing Jing
    Wang, Huan Huan
    Gao, Zhan
    Wang, Miao
    Yuan, Jin Qing
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2017, 30 (12) : 898 - +
  • [36] Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial
    Park, Kyung Woo
    Park, Jin Joo
    Lee, Seung-Pyo
    Oh, Il-Young
    Suh, Jung-Won
    Yang, Han-Mo
    Lee, Hae-Young
    Kang, Hyun-Jae
    Cho, Young-Suk
    Koo, Bon-Kwon
    Youn, Tae-Jin
    Chae, In-Ho
    Choi, Dong-Ju
    Oh, Byung-Hee
    Park, Young-Bae
    Kim, Hyo-Soo
    HEART, 2011, 97 (08) : 641 - 647
  • [37] Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy
    Yu Wu
    Yilun Zhou
    Yuesong Pan
    Xingquan Zhao
    Liping Liu
    David Wang
    Chunxue Wang
    Hao Li
    S. Claiborne Johnston
    Xia Meng
    Yilong Wang
    Yongjun Wang
    The Pharmacogenomics Journal, 2018, 18 : 713 - 720
  • [38] Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy
    Wu, Yu
    Zhou, Yilun
    Pan, Yuesong
    Zhao, Xingquan
    Liu, Liping
    Wang, David
    Wang, Chunxue
    Li, Hao
    Johnston, S. Claiborne
    Meng, Xia
    Wang, Yilong
    Wang, Yongjun
    PHARMACOGENOMICS JOURNAL, 2018, 18 (06): : 713 - 720
  • [39] ANTIPLATELET THERAPY WITH CLOPIDOGREL TAKING INTO ACCOUNT CYP2C19 GENETIC POLYMORPHISMS IN PATIENTS WITH CORONARY HEART DISEASE AFTER CORONARY ARTERY STENTING
    Uzokov, J.
    Alyavi, B.
    Abdullaev, A.
    Muxitdinova, O.
    Ubaydullaeva, Z.
    ATHEROSCLEROSIS, 2021, 331 : E265 - E265
  • [40] The impact of CYP2C19*2, CYP4F2*3, and clinical factors on platelet aggregation, CYP4F2 enzyme activity, and 20-hydroxyeicosatetraenoic acid concentration in patients treated with dual antiplatelet therapy
    Tatarunas, Vacis
    Kupstyte, Nora
    Giedraitiene, Agne
    Skipskis, Vilius
    Jakstas, Valdas
    Zvikas, Vaidotas
    Lesauskaite, Vaiva
    BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (08) : 658 - 664
12345